文献速递前列腺增生与排尿功能障碍男科与性医学

经会阴激光消融术与经尿道前列腺电切术治疗良性前列腺梗阻后射精功能的随机试验

Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial.
PubMed 文献 · BJU Int · 2023-03-30

这项单中心、前瞻性、随机、开放标签研究纳入51例良性前列腺梗阻患者,随机分为经会阴间质激光消融术组(TPLA组,26例)与经尿道前列腺电切术组(TURP组,25例)。术后1个月TPLA组射精功能(EJ-MSHQ)分布未改变(P=0.2),TURP组EJ-MSHQ评分中位下降30%(P=0.01);TPLA组1例、TURP组18例报告无顺行射精。两组术后Qmax差异有统计学意义(TPLA组15.2 mL/s vs TURP组26.0 mL/s,P<0.001)。作者结论为TPLA在96%的病例中保留了射精功能,同时显著缓解良性前列腺梗阻症状。

要点

  • TPLA组术后1个月EJ-MSHQ评分分布未改变(P=0.2),TURP组中位下降30%(P=0.01)。
  • 无顺行射精者TPLA组1例,TURP组18例。
  • 两组术后Qmax差异有统计学意义(TPLA组15.2 mL/s vs TURP组26.0 mL/s,P<0.001)。

核心结论

  • 作者结论为TPLA在96%的病例中保留了射精功能,同时显著缓解良性前列腺梗阻症状。

研究设计与样本

  • 单中心、前瞻性、随机、开放标签研究,2020年1月至2021年9月连续纳入有手术指征的良性前列腺梗阻患者(NCT04781049)。
  • 患者随机分为A组TPLA(实验组)与B组TURP(参考标准组),共分析51例(TPLA组26例 vs TURP组25例)。

主要发现

  • 术后1个月TPLA组EJ-MSHQ评分分布未改变(P=0.2),TURP组EJ-MSHQ评分中位下降30%(P=0.01)。
  • 无顺行射精者TPLA组1例,TURP组18例。
  • 两组VAS疼痛感知无差异,IIEF-5评分无差异。
  • 术后Qmax组间差异有统计学意义:TPLA组15.2(四分位距13.5-18.3)mL/s vs TURP组26.0(四分位距22.0-48.0)mL/s,P<0.001。
  • 两种治疗均显著改善Qmax,TURP组平均改善23.9 mL/s(95%CI 17.1-30.7)vs TPLA组6.0 mL/s(95%CI 5.0-7.0);IPSS平均下降TURP组11.6(95%CI 9.7-13.5)vs TPLA组5.8(95%CI 2-9.6)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the reliability of transperineal interstitial laser ablation of the prostate (TPLA) in preserving antegrade ejaculation compared to transurethral resection of the prostate (TURP). PATIENTS AND METHODS: In this single-centre, prospective, randomized, open-label study, consecutive patients with indication for surgical treatment for benign prostatic obstruction (BPO) were enrolled between January 2020 and September 2021 (NCT04781049). Patients were randomized to one of two treatment arms: Group A: TPLA (experimental group) and Group B: TURP (reference standard group). The primary endpoint was change in ejaculatory function (assessed by the Male Sexual Health Questionnaire - Ejaculatory function domain [EJ-MSHQ]) at 1 month after surgery. Secondary endpoints included comparison of visual analogue scale (VAS) scores, changes in sexual function (assessed using the five-item International Index of Erectile Function [IIEF-5]), change in International Prostate Symptom Score [IPSS], change in quality of life score, and maximum urinary flow rate [Qmax ] improvement at 1-6 months, as appropriate. RESULTS: Fifty-one patients (26 TPLA vs 25 TURP) were analysed. No differences in the perception of pain assessed by VAS and no differences in IIEF-5 score were found between the groups. The distribution of ejaculatory function assessed by the EJ-MSHQ remained unmodified after TPLA (P = 0.2), while a median 30% decrease in EJ-MSHQ score was observed after TURP (P = 0.01). Absence of antegrade ejaculation was reported in one patient in the TPLA group (vs 18 patients in the TURP group). A statistically significant difference between the treatment groups was found in terms of postoperative Qmax (TPLA vs TURP: 15.2 [interquartile range 13.5-18.3] mL/s vs 26.0 [interquartile range 22.0-48.0] mL/s; P < 0.001). Both treatments significantly improved Qmax , with a mean 23.9 mL/s improvement after TURP (95% confidence interval [CI] 17.1-30.7) vs 6.0 mL/s after TPLA (95% CI 5.0-7.0), and IPSS, with a mean decrease of 11.6 (95% CI 9.7-13.5) vs 5.8 after TPLA (95% CI.2-9.6) with respect to baseline. CONCLUSION: In our study, TPLA preserved ejaculatory function in 96% of cases in addition to providing significant relief from BPO.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Bertolo R, Iacovelli V, Cipriani C, et al. Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial. BJU Int. 2023. PMID: 36917033. doi:10.1111/bju.16008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。